New-onset Chronic Pelvic Pain in Transgender People Using Testosterone Therapy: an Exploratory Qualitative Study.
Status
Conditions
Details and patient eligibility
About
This descriptive qualitative study aim to describe the characteristics of pelvic pain in transgender (trans) individuals using testosterone therapy and the impact on their quality of life. This study also aim to understand the levers and obstacles to consulting a health care professional.
Full description
This study ai to accurately describe the chronic pelvic plan (CPP) from which transmasculine people can suffer, as well as their impact on quality of life, and to understand what are the obstacles and levers to the implementation of adapted care.
Method: It is an observational, single-center, qualitative study. 10 to 15 trans individuals using testosterone therapy and having pelvic pain for at least 6 months, and that had appeared or changed since taking testosterone, will undergo a semi-structured interview. They will be recruited through community care associations, mailing lists and flyers.
Results: This is a qualitative study aimed at accurately describing the symptoms of pelvic pain experienced by trans people thus we will do a qualitative analysis. QCAMAPS will be used for the coding step.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Being a trans masculine individual
- Taking a gender affirming hormonal therapy (GAHT)
- living close to Grenoble
- having pelvic pain that appeared or were modified after taking GAHT
Exclusion criteria
- Subject under guardianship or subject deprived of liberty Refusal of voice recording
Trial contacts and locations
Loading...
Central trial contact
SaraEve Graham Longsworth, MSc
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal